Curing Cancer: The Philadelphia Award and Dr. Carl June

In 2013, Carl June, MD, won the Philadelphia Award for his pioneering work in the use of engineered chimeric antigen-modified T cells (so-called "killer" T Cells) to treat acute lymphoid leukemia and chronic lymphocytic leukemia.

Related Links

• "View Clinical Briefing: Enrolling Clinical Trials: Adoptive Immunotherapy for Chemotherapy Resistant or Refractory CD-19+ Leukemia and Lymphoma"
• "View Case Study: A 65-year-old male treated with adoptive immunotherapy (CTL-019) for relapsed chronic lymphocytic leukemia."
• View Dr June's Profile